New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities

10.1016/j.biopha.2021.111824

Saved in:
Bibliographic Details
Main Authors: Ashrafizadeh, Milad, Mirzaei, Sepideh, Hashemi, Farid, Zarrabi, Ali, Zabolian, Amirhossein, Saleki, Hossein, Sharifzadeh, Seyed Omid, Soleymani, Leyla, Daneshi, Salman, Hushmandi, Kiavash, Khan, Haroon, Kumar, Alan Prem, Aref, Amir Reza, Samarghandian, Saeed
Other Authors: PHARMACOLOGY
Format: Review
Published: Elsevier Masson s.r.l. 2022
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/232419
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-232419
record_format dspace
spelling sg-nus-scholar.10635-2324192024-04-04T04:01:31Z New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities Ashrafizadeh, Milad Mirzaei, Sepideh Hashemi, Farid Zarrabi, Ali Zabolian, Amirhossein Saleki, Hossein Sharifzadeh, Seyed Omid Soleymani, Leyla Daneshi, Salman Hushmandi, Kiavash Khan, Haroon Kumar, Alan Prem Aref, Amir Reza Samarghandian, Saeed PHARMACOLOGY Chemoresistance Docetaxel Drug resistance Epithelial-to-mesenchymal transition (EMT) Metastasis Paclitaxel 10.1016/j.biopha.2021.111824 Biomedicine and Pharmacotherapy 141 111824 2022-10-12T08:03:13Z 2022-10-12T08:03:13Z 2021-09-01 Review Ashrafizadeh, Milad, Mirzaei, Sepideh, Hashemi, Farid, Zarrabi, Ali, Zabolian, Amirhossein, Saleki, Hossein, Sharifzadeh, Seyed Omid, Soleymani, Leyla, Daneshi, Salman, Hushmandi, Kiavash, Khan, Haroon, Kumar, Alan Prem, Aref, Amir Reza, Samarghandian, Saeed (2021-09-01). New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities. Biomedicine and Pharmacotherapy 141 : 111824. ScholarBank@NUS Repository. https://doi.org/10.1016/j.biopha.2021.111824 0753-3322 https://scholarbank.nus.edu.sg/handle/10635/232419 Attribution-NonCommercial-NoDerivatives 4.0 International https://creativecommons.org/licenses/by-nc-nd/4.0/ Elsevier Masson s.r.l. Scopus OA2021
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic Chemoresistance
Docetaxel
Drug resistance
Epithelial-to-mesenchymal transition (EMT)
Metastasis
Paclitaxel
spellingShingle Chemoresistance
Docetaxel
Drug resistance
Epithelial-to-mesenchymal transition (EMT)
Metastasis
Paclitaxel
Ashrafizadeh, Milad
Mirzaei, Sepideh
Hashemi, Farid
Zarrabi, Ali
Zabolian, Amirhossein
Saleki, Hossein
Sharifzadeh, Seyed Omid
Soleymani, Leyla
Daneshi, Salman
Hushmandi, Kiavash
Khan, Haroon
Kumar, Alan Prem
Aref, Amir Reza
Samarghandian, Saeed
New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
description 10.1016/j.biopha.2021.111824
author2 PHARMACOLOGY
author_facet PHARMACOLOGY
Ashrafizadeh, Milad
Mirzaei, Sepideh
Hashemi, Farid
Zarrabi, Ali
Zabolian, Amirhossein
Saleki, Hossein
Sharifzadeh, Seyed Omid
Soleymani, Leyla
Daneshi, Salman
Hushmandi, Kiavash
Khan, Haroon
Kumar, Alan Prem
Aref, Amir Reza
Samarghandian, Saeed
format Review
author Ashrafizadeh, Milad
Mirzaei, Sepideh
Hashemi, Farid
Zarrabi, Ali
Zabolian, Amirhossein
Saleki, Hossein
Sharifzadeh, Seyed Omid
Soleymani, Leyla
Daneshi, Salman
Hushmandi, Kiavash
Khan, Haroon
Kumar, Alan Prem
Aref, Amir Reza
Samarghandian, Saeed
author_sort Ashrafizadeh, Milad
title New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
title_short New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
title_full New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
title_fullStr New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
title_full_unstemmed New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
title_sort new insight towards development of paclitaxel and docetaxel resistance in cancer cells: emt as a novel molecular mechanism and therapeutic possibilities
publisher Elsevier Masson s.r.l.
publishDate 2022
url https://scholarbank.nus.edu.sg/handle/10635/232419
_version_ 1800915611632533504